Johnson & Johnson buy TD Cowen
Start price
19.07.24
/
50%
€142.98
Target price
19.07.25
€169.72
Performance (%)
-1.22%
End price
20.07.25
€141.24
Summary
This prediction ended on 20.07.25 with a price of €141.24. With a performance of -1.22%, the BUY prediction by TD_Cowen finished with a loss. Dividends of €3.48 are taken into consideration when calculating the performance. TD_Cowen has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Johnson & Johnson | -0.704% | -0.704% | 27.227% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by TD_Cowen for this prediction
In the thread Johnson & Johnson diskutieren
Johnson & Johnson (NYSE: JNJ) had its price target lowered by analysts at TD Cowen from $195.00 to $185.00. They now have a "buy" rating on the stock.
Ratings data for JNJ provided by MarketBeat
In the thread Trading Johnson & Johnson
Die von TD_Cowen gewählte maximale Laufzeit wurde überschritten